Modern methods of conservative and surgical treatment of patients with lower limb varicose vein disease (in Russian only)

Close metadata

Recommended articles:

Results of surgical treatment in patients with critical ischemia of the lower limbs and complications of endovascular interventions. Russian Journal of Cardiology and Cardiovascular Surgery. 2017;(1):47-50

Early and Long-term results of surgical treatment of combined carotid and coronary atherosclerotic lesion. Russian Journal of Cardiology and Cardiovascular Surgery. 2017;(1):22-27

Surgical myectomy in patients with obstructive hypertrophic cardiomyopathy and concomitant cardiac diseases. Russian Journal of Cardiology and Cardiovascular Surgery. 2023;(3):297-308

Modern view on postoperative perineal hernias surgical treatment. Russian Journal of Operative Surgery and Clinical Anatomy. 2023;(1):34-40

Postoperative pain assessment in patients with Crohn’s disease. Russian Journal of Evidence-Based Gastroenterology. 2023;(1):37-41

Compliance with 15—20 mm Hg Compression Pantyhose in Female Patients with C0S-C2S Chronic Venous Disease. Journal of Venous Disorders. 2023;(1):18-25

Venoactive Drug Treatment or Compression Stockings in Warm Weather Season in Symptomatic Patients with Chronic Venous Disease. Journal of Venous Disorders. 2023;(1):26-33

Surgery for lung cancer in elderly and senile patients: a ten-year experience of two centers. P.A. Herzen Journal of Oncology. 2023;(2):11-18

Problems of a comprehensive assessment of the malignancy potential of pancreatic cystic neoplasia using endoscopic ultrasonography and fine needle aspiration puncture. Endoscopic Surgery. 2023;(2):11-18

Primary spine and spinal cord tumours and pregnancy. Russian Bulletin of Obstetrician-Gynecologist. 2023;(2):88-94

Prevalence of chronic venous diseases is analyzed in the article. Various researches devoted to various methods of conservative and surgical treatment of this disease are reviewed. The main unsolved problems are emphasized.

Keywords:

chronic venous diseases

chronic venous insufficiency

lower limb varicose vein disease

conservative treatment

surgical treatment

Authors:

K.P. Chernykh

St. Petersburg City Aleksandrovskaya Hospital, Saint-Petersburg, Russia

K.G. Kubachev

GBUZ "Aleksandrovskaia bol'nitsa", Sankt-Peterburg

A.Yu. Semenov

Medical Innovative Phlebological Center, Moscow, Russia

K.V. Malyshev

MUZ Gorodskaia klinicheskaia bol'nitsa #18, Kazan'

List of references:

Davies AH. The Seriousness of Chronic Venous Disease: A Review of Real-World Evidence. AdvTher. 2019 Feb 13. doi: 10.1007/s12325-019-0881-7
das Gracas CdSM, Cyrino FZ, de Carvalho JJ, Blanc-Guillemaud V, Bouskela E. Protective effects of micronized purified flavonoid fraction (MPFF) on a novel experimental model of chronic venous hypertension. Eur J Vasc Endovasc Surg. 2018;55(5): 694-702.
Wrona M, Jockel KH, Pannier F, Bock E, Hoffmann B, Rabe E. Association of Venous Disorders with Leg Symptoms: Results from the Bonn Vein Study 1. Eur J Vasc Endovasc Surg. 2015;50:360-367. doi: 10.1016/j.ejvs.2015.05.013
Lee AJ, Robertson LA, Boghossian SM, Allan PL, Ruckley CV, Fowkes FG, Evans CJ. Progression of varicose veins and chronic venous insufficiency in the general population in the Edinburgh Vein Study. J Vasc Surg Venous Lymphat Disord. 2015;3:18-26. doi: 10.1016/j.jvsv.2014.09.008
Martinez-Zapata MJ, Vernooij RW, UrionaTuma SM, Stein AT, Moreno RM, Vargas E, Capella D, Bonfill Cosp X. Phlebotonics for venous insufficiency. Cochrane Database Syst Rev. 2016;4: CD003229. doi: 10.1002/14651858.CD003229.pub3
Kakkos SK, Nicolaides AN. Efficacy of micronized purified flavonoid fraction Daflon® on improving individual symptoms, signs and quality of life in patients with chronic venous disease: A systematic review and meta-analysis of randomized double-blind placebo-controlled trials. Int Angiol. 2018;37:143-154.
Tsukanov YuT, Tsukanov AYu. Diagnosis and treatment of situational great saphenous vein reflux in daily medical practice. Phlebolymphology. 2017;24(3):144-151.
Ibegbuna V, Nicolaides AN, Sowade O, Leon M, Geroulakos G. Venous elasticity after treatment with Daflon 500 mg. Angiology. 1997;48:45-49. doi: 10.1177/000331979704800108
Pietrzycka A, Kozka M, Urbanek T, Stpniewski M, Kucharzewski M. Effect of Micronized Purified Flavonoid Fraction Therapy on Endothelin-1 and TNF-alpha Levels in Relation to Antioxidant Enzyme Balance in the Peripheral Blood of Women with Varicose Veins. Curr Vasc Pharmacol. 2015;13:801-808. doi: 10.2174/1570161113666150827124714
Blume J, Langenbahn H, Champvallins M. Quantification of edema using the volometer technique; therapeutic application of Daflon 500 mg in chronic venous insufficiency. Phlebology. 1992;7:37-40.
Tsukanov YuT, Nikolaichuk AI. Orthostatic-loading-induced transient venous refluxes (day orthostatic loading test), and remedial effect of micronized purified flavonoid fraction in patients with telangiectasia and reticular vein. Int Angiol. 2017;36:189-196.
Tsukanov YuT, Tsukanov AYu. Diagnosis and treatment of situational great saphenous vein reflux in daily medical practice. Phlebolymphology. 2017;24:144-151.
Roztocil K, Stvrtinova V, Strejcek J. Efficacy of a 6-month treatment with Daflon 500 mg in patients with venous leg ulcers associated with chronic venous insufficiency. Int Angiol. 2003;22:24-31.
Jantet G. Chronic venous insufficiency: Worldwide results of the RELIEF study. Reflux ass Essessment and quality of lIfeimprovement with micronized Flavonoids. Angiology. 2002;53:245-256. doi: 10.1177/000331970205300301
Nikfarjam BA, Adineh M, Hajiali F, Nassiri-Asl M. Treatment with Rutin — A Therapeutic Strategy for Neutrophil-Mediated Inflammatory and Autoimmune Diseases —Antiinflammatory Effects of Rutin on Neutrophils. J Pharmacopunct. 2017;20:52-56.
Vanscheidt W, Rabe E, Naser-Hijazi B, Ramelet AA, Partsch H, Diehm C, Schultz-Ehrenburg U, Spengel F, Wirsching M, Gotz V, et al. The efficacy and safety of a coumarin-/troxerutin-combination (SB-LOT) in patients with chronic venous insufficiency: A double blind placebo-controlled randomised study. VASA. 2002;31:185-190. doi: 10.1024/0301-1526.31.3.185
Rabe E, Jaeger KA, Bulitta M, Pannier F. Calcium dobesilate in patients suffering from chronic venous insufficiency: A double-blind, placebo-controlled, clinical trial. Phlebology. 2011;26:162-168. doi: 10.1258/phleb.2010.010051
Widmer L, Biland L, Barras JP. Doxium 500 in chronic venous insufficiency: A double-blind placebo controlled multicentre study. Int Angiol. 1990;9:105-110.
Martinez-Zapata MJ, Moreno RM, Gich I, Urrutia G, Bonfill X. A randomized, double-blind multicentre clinical trial comparing the efficacy of calcium dobesilate with placebo in the treatment of chronic venous disease. Eur J Vasc Endovasc Surg. 2008;35:358-365. doi: 10.1016/j.ejvs.2007.08.012
Coccheri S, Mannello F. Development and use of sulodexide in vascular diseases: Implications for treatment. Drug Des Dev Ther. 2013;8:49-65. doi: 10.2147/DDDT.S6762
Mannello F, Ligi D, Raffetto JD. Glycosaminoglycan sulodexide modulates inflammatory pathways in chronic venous disease. Int Angiol. 2014;33:236-242.
Pletinck A, Van Landschoot M, Steppan S, Laukens D, Passlick-Deetjen J, Vanholder R, van Biesen W. Oral supplementation with sulodexide inhibits neo-angiogenesis in a rat model of peritoneal perfusion. Nephrol Dial Transplant. 2012;27:548-556. doi: 10.1093/ndt/gfr370
Ligi D, Mosti G, Croce L, Raffetto JD, Mannello F. Chronic venous disease—Part I: Inflammatory biomarkers in wound healing. Biochim Biophys Acta. 2016;1862:1964-1974. doi: 10.1016/j.bbadis.2016.07.018
Ligi D, Mosti G, Croce L, Raffetto JD, Mannello F. Chronic venous disease—Part II: Proteolytic biomarkers in wound healing. Biochim Biophys Acta. 2016;1862:1900-1908. doi: 10.1016/j.bbadis.2016.07.011
Elleuch N, Zidi H, Bellamine Z, Hamdane A, Guerchi M, Jellazi N. Sulodexide in Patients with Chronic Venous Disease of the Lower Limbs: Clinical Efficacy and Impact on Quality of Life. Adv Ther. 2016;33:1536-1549. doi: 10.1007/s12325-016-0359-9
Gonzalez Ochoa A. Sulodexide and phlebotonics in the treatment of venous ulcer. Int Angiol. 2017;36:82-87.
Wu B, Lu J, Yang M, Xu T. Sulodexide for treating venous leg ulcers. Cochrane Database Syst Rev. 2016;CD010694. doi: 10.1002/14651858.CD010694.pub2
Lee BB, Nicolaides AN, Myers K, Meissner M, Kalodiki E, Allegra C, Antignani PL, Baekgaard N, Beach K, Belcaro G, et al. Venous hemodynamic changes in lower limb venous disease: The UIP consensus according to scientific evidence. Int Angiol. 2016;35:236-352.
Novak CJ, Khimani N, Kaye AD, Jason Yong R, Urman RD. Current Therapeutic Interventions in Lower Extremity Venous Insufficiency: a Comprehensive Review. Curr Pain Headache Rep. 2019 Mar 4;23(3):16. doi: 10.1007/s11916-019-0759-z
Cabrera J, Cabrera JJ, Garcia-Olmedo MA. Treatment of varicose long saphenous veins with sclerosant in microfoam form: long-term outcomes. Phlebology. 2000;15:19-23.
Wright D, Gobin JP, Bradbury A, Coleridge-Smith P, Spoelstra H, Berridge D, et al. Varisolvepolidocanolmicrofoam compared with surgery or sclerotherapy in the management of varicose veins in the presence of trunk vein incompetence: European randomised controlled trial. Phlebology. 2006;21:180-190.
Lawaetz M, Serup J, Lawaetz B, Bjoern L, Blemings A, Ecklof E, et al. Comparison of endovenous ablation techniques, foam sclerotherapy and surgical stripping for great saphenous varicose veins. Extended 5-year follow-up of a RCT. Int Angiol. 2017;36(3):281-285.
Vähäaho S, Halmesmäki K, Albäck A, Saarinen E, Venermo M. Five-year follow-up of a randomized clinical trial comparing open surgery, foam sclerotherapy and endovenous laser ablation for great saphenous varicose veins. BJS. 2018;105:686-691.
Gibson K, Ferris B. Cyanoacrylate closure of incompetent great, small and accessory saphenous veins without the use of post-procedure compression: initial outcomes of a post-market evaluation of the VenaSeal System (the WAVES Study). Vascular. 2017;25(2): 149-156.
Morrison N, Gibson K, McEnroe S, Goldman M, King T, Weiss R, et al. Randomized trial comparing cryanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins (VeClose). J Vasc Surg. 2015;61(4):985-994.
Venermo M, Saarinen E, Eskelinen E, Vähäaho S. Saarinen, et al. Randomized clinical trial comparing surgery, endovenous laser ablation and ultrasound-guided foam sclerotherapy for the treatment of great saphenous varicose veins. Br J Surg. 2016;103(11):1438-1444.
Brittenden J, Cotton SC, Elders A, et al. A randomized trial comparing treatments for varicose veins. N Engl J Med. 2014;1218:371.
Almeida JI, Kaufman J, Göckeritz O, Chopra P, Evans MT, et al. Radiofrequency endovenous Closure FAST versus laser ablation for the treatment of great saphenous reflux: a multicenter, single-blinded, randomized study (RECOVERY study). J Vasc Interv Radiol. 2009;20(6):752-759.
Rasmussen L, Lawaetz M, Serup J, et al. Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins and 3-year follow-up. J Vasc SurgVenous Lymphat Disord. 2013;1(4):349-356.
Van der Velden SK, Biemans AA, De Maeseneer MG, Kockaert MA, Cuypers PW, et al. A five-year results of a randomized clinical trial of conventional surgery, endovenous laser ablation and ultrasound-guided foam sclerotherapy in patients with great saphenous varicose veins. Br J Surg. 2015;102(10):1184-1194.

Close metadata